While continuous administration of α-IL-10 from 4 weeks of age onwards could delay autoantibody formation and lupus manifestation in NZB/W F1 animals [48], a deficiency of IL-10 in MRL-Faslpr mice induced lupus symptoms and autoantibodies [47]. Here, IL10 is linked to systemic lupus erythematosus.